申请人:Grünenthal GmbH
公开号:US20140194452A1
公开(公告)日:2014-07-10
The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
这项发明涉及以吡唑基为基础的羧酰胺化合物,其作为ICRAC抑制剂有用,以及含有这些化合物的药物组合物,以及这些化合物在治疗和/或预防疾病和/或疾病中的用途,特别是炎症性疾病和/或炎症性疾病。